Discounted Cash Flow
Goodrx Holdings, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2018 | $249.5m | $43.8m | $44.4m | 17.6% | $0.39 |
| 2019 | $388.2m (55.6%) | $66.0m (50.8%) | $81.9m (84.2%) | 17.0% (-3.1%) | $0.29 (-25.6%) |
| 2020 | $550.7m (41.9%) | $-293.6m (-544.6%) | $110.8m (35.3%) | -53.3% (-413.4%) | $-1.07 (-466.7%) |
| 2021 | $745.4m (35.4%) | $-25.3m (91.4%) | $174.2m (57.2%) | -3.4% (93.6%) | $-0.06 (94.2%) |
| 2022 | $766.6m (2.8%) | $-32.8m (-30.0%) | $142.8m (-18.0%) | -4.3% (-26.4%) | $-0.08 (-29.1%) |
| 2023 | $750.3m (-2.1%) | $-8.9m (73.0%) | $-8.9m (-106.2%) | -1.2% (72.4%) | $-0.02 (72.8%) |
| 2024 | $792.3m (5.6%) | $16.4m (284.8%) | $16.4m (284.8%) | 2.1% (275.0%) | $0.04 (296.6%) |
| 2025 | $796.9m (0.6%) | $30.4m (85.7%) | $164.4m (902.9%) | 3.8% (84.7%) | $0.09 (101.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.